» Articles » PMID: 39281749

Gut Microbiome Compositional and Functional Features Associate with Alzheimer's Disease Pathology

Abstract

Background: The gut microbiome is a potentially modifiable factor in Alzheimer's disease (AD); however, understanding of its composition and function regarding AD pathology is limited.

Methods: Shallow-shotgun metagenomic data was used to analyze fecal microbiome from participants enrolled in the Wisconsin Microbiome in Alzheimer's Risk Study, leveraging clinical data and cerebrospinal fluid (CSF) biomarkers. Differential abundance and ordinary least squares regression analyses were performed to find differentially abundant gut microbiome features and their associations with CSF biomarkers of AD and related pathologies.

Results: Gut microbiome composition and function differed between people with AD and cognitively unimpaired individuals. The compositional difference was replicated in an independent cohort. Differentially abundant gut microbiome features were associated with CSF biomarkers of AD and related pathologies.

Discussion: These findings enhance our understanding of alterations in gut microbial composition and function in AD, and suggest that gut microbes and their pathways are linked to AD pathology.

References
1.
Virtanen P, Gommers R, Oliphant T, Haberland M, Reddy T, Cournapeau D . SciPy 1.0: fundamental algorithms for scientific computing in Python. Nat Methods. 2020; 17(3):261-272. PMC: 7056644. DOI: 10.1038/s41592-019-0686-2. View

2.
Xiao-Hang Q, Si-Yue C, Hui-Dong T . Multi-strain probiotics ameliorate Alzheimer's-like cognitive impairment and pathological changes through the AKT/GSK-3β pathway in senescence-accelerated mouse prone 8 mice. Brain Behav Immun. 2024; 119:14-27. DOI: 10.1016/j.bbi.2024.03.031. View

3.
Zhu Q, Huang S, Gonzalez A, McGrath I, McDonald D, Haiminen N . Phylogeny-Aware Analysis of Metagenome Community Ecology Based on Matched Reference Genomes while Bypassing Taxonomy. mSystems. 2022; 7(2):e0016722. PMC: 9040630. DOI: 10.1128/msystems.00167-22. View

4.
Nagpal R, Neth B, Wang S, Craft S, Yadav H . Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer's disease markers in subjects with mild cognitive impairment. EBioMedicine. 2019; 47:529-542. PMC: 6796564. DOI: 10.1016/j.ebiom.2019.08.032. View

5.
Betthauser T, Koscik R, Jonaitis E, Allison S, Cody K, Erickson C . Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age. Brain. 2019; 143(1):320-335. PMC: 6935717. DOI: 10.1093/brain/awz378. View